Benjamin CHARLES

Benjamin Charles has extensive work experience in various roles and industries. Benjamin co-founded DiogenX in 2019, where they currently serve as the Chief Executive Officer. Prior to this, they co-founded and held the position of Chief Business Officer at Imcheck Therapeutics from 2015 to 2019.

Benjamin also worked as a Business Development Manager at Inserm Transfert from 2012 to 2015, and as a Consultant (healthcare) and M&A analyst at AEC Partners from 2009 to 2012. Benjamin gained further experience as a Consultant (healthcare) at Publicis Healthcare Consulting in 2011.

Earlier in their career, Benjamin gained valuable experience as an M&A intern at BNP Paribas from 2008 to 2009, and as a Business Analyst at Smart Pharma Consulting in 2007. Benjamin started their professional journey as an intern in pharmacy at the Nancy Regional Teaching Hospital from 2005 to 2006.

Benjamin Charles completed their education in a chronological order. From 2006 to 2009, they attended ESSEC Business School, where they obtained their MBA degree. Prior to that, they pursued a PharmD/Doctorate in Pharmaceutical Sciences at Université Henri Poincaré, Nancy 1 from 2001 to 2008. Additionally, in 2004 and 2005, Benjamin completed their 4th year of studies at the University of Brighton, specifically in the Faculty of Pharmacy. No specific field of study is mentioned for their MBA and PharmD degrees.